Positron emission tomography in the evaluation of breast lesions;Die positronen-emissions-tomographie in der diagnostik von mammatumoren

Geburtshilfe und Frauenheilkunde

Volumn 60, Issue 1, 2000, Pages 59-62

  Dormeier, Anke ^a   Bahre M ^a   Lauer, I ^a   Germer, U ^a   Meller, B ^a   Geipel, A ^a   Diedrich, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST TUMOR; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMOGRAPHY; POSITRON EMISSION TOMOGRAPHY;

EID: 17544389528     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9767     Document Type: Article

References (24)

1. Warburg O. On the origin of cancer cells. Science 1926; 123: 309 -314
2. Warburg O. The metabolism of tumors. New York: Richard R. Smith Inc., 1931
3. Shields AF, Lim K, Grierson J, Link J, Krohn KA. Utilisation of labeled Thymidine in DNA synthesis, studies for PET. J Nucl Med 1990; 31: 337-342
4. Som P, Atkins HI, Bandophathyah D, Fowlers JS, MacGregor RR, Matsui K, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21: 670-675
5. Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffmann EJ, Schiepers C, et al. Cancer detection with whole body PET using 2-fluoro-2-deoxy-D-glucose (F18). J Comput Assist Tomogr 1993; 17: 582-589
6. Hiraki Y, Rosen OM, Birnbaum MJ. Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 1988; 263: 13655-13662
7. Minn H, Zasadny KR, Quint LE, Wahl RL Lung cancer: reproducibility of quantitative measurement for evaluating 2-F18-fluoro-2-deoxy-D-glucose uptake in PET. Radiolog 1995; 196: 167-173
8. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648
9. Ogawa T, Kanno I, Shishido F. Clinical value of PET with F-18-fluorodeoxyglucose and 1-methyl-C-11-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991; 32: 197-202
10. 18F-fluorodeoxy-glucose PET. Amer J Roentgenol 1994; 163: 1459-1465
11. Rigo P, de-Lansheere C, Melon P, Kulbertus H. Imaging of myocardial metabolism by positron emission tomography. Cardiosc Drugs Ther 1990; 4: 847-851
12. Gould KL. Positron emission tomography and interventional cardiology. Amer J Cardiol 1990; 26; 66(14): 51F-58F
13. Lewis P, Griffin S, Marsden P, Gee T, Nunan T, Malsey M. Wholebody 18-F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994; 344: 1265-1266
14. Inoue T, Kim EE, Kmaki R, Wong FCL, Bassa P, Wong WA. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36: 788-793
15. Luig H. Rekonstruktionsverfahren in der Gammaquanten-Tomographie/SPECT. Der Nuklearmediziner 1991; 14(2): 65-73
16. 99mTc sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196: 421-426
17. 99mTc sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-1765
18. Kopans DB. The positive predictive value of mammography. Amer J Roentgenol 1992; 158: 521-526
19. Tiling R, Sommer H, Pechmann M, Moser R, Kress K, Pfluger T, Tatsch K, Hahn K. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. J Nucl Med 1997; 38: 58-62
20. Palmedo H, Grünwald F, Bender H, Schomburg A, Mallmann P, Krebs D, Biersack HJ. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996; 23: 940-946
21. 99mTc-tetrofosmin scintimammography: a prospective study in primary breast lesions. Nuklearmedizin 1996; 35: 225-229
22. Lawrence WF, Liang W, Mandelblatt JS, Gold KF, Freedman M, Ascher SM, Trock BJ, Chang P. Serendipity in diagnostic imaging: magnetic resonance imaging of the breast. J Natl Cancer Inst 1998; 90: 1792-1800
23. Dujim LEM, Guit GL, Zaat JOM, Koomen AR, Willebrand D. Sensitivity, specificity and predictive values of breast imaging in the detection of cancer. Brit J Cancer 1997; 76: 377-381
24. Yutani K, Tatsumi M, Shiba E, Kusuoka H, Nishimura T. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis. J Nucl Med 1999; 40: 1003-1009